Nieuws Wie zijn we? Wat doen we? Praktisch Waar vind je ons? Uitstraling
Nederlands | Français | English
Print | Sitemap | Links | Contact | Home | Colofon 
 
Zoeken  
 
 
Wetenschappelijk netwerk
Historiek
In de pers
Onderzoeksgroepen
Publicaties
Publicaties uit 2011
Publicaties uit 2010
Publicaties uit 2009
Publicaties uit 2008
Publicaties uit 2007
Publicaties uit 2006
Publicaties uit 2005
Publicaties uit 2004
Publicaties uit 2003
Publicaties uit 2002
Publicaties uit 2001
Publicaties uit 2000
Publicaties uit 1999
Publicaties uit 1998
Publicaties uit 1997
Publicaties uit 1996
Publicaties uit 1995
Publicaties uit 1994
Publicaties uit 1993
Publicaties uit 1992
Publicaties uit 1991
Publicaties uit 1990
Publicaties uit 1989
Publicaties uit 1988
Publicaties uit 1987
Publicaties uit 1986
Publicaties uit 1985
Publicaties uit 1984
Publicaties uit 1983
 
Proefschriften
Opleidingen
 
  Uitstraling  Publicaties

Publicaties uit 2006


  1. Anckaert E, Platteau P, Schiettecatte J, Devroey P, Van Steirteghem A, Smitz J. Spuriously elevated serum estradiol concentrations measured by an automated immunoassay rarely cause unnecessary cancellation of in vitro fertilization cycles. Fertil Steril, 85, 1822.e5-8, 2006.
  2. Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21, 3217-27, 2006.
  3. Arce JC, Ziebe S, Lundin K, Janssens R, Helmgaard L, Sorensen P. Interobserver agreement and intraobserver reproducibility of embryo quality assessments. Hum Reprod, 21, 2141-8, 2006
  4. Balen AH, Platteau P, Andersen AN, Devroey P, Sorensen P, Helmgaard L, Arce JC. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility.BJOG. 2006 113(10), 1195-202, 2006.
  5. Beckers NG, Platteau P, Eijkemans MJ, Macklon NS, de Jong FH, Devroey P, Fauser BC. The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. Eur J Endocrinol,155(2):355-63, 2006.
  6. Belva F, Henriet S, Liebaers I, Van Steirteghem A, Celestin-Westreich S, Bonduelle M. Medical outcome of 8-year-old singleton ICSI children (born >=32 weeks' gestation) and a spontaneously conceived comparison group. Hum Reprod, 22, 506-515, 2006.
  7. Brugnon F, Van Assche E, Verheyen G, Sion B, Boucher D, Pouly JL, Janny L, Devroey P; Liebaers I, Van Steirteghem A. Study of two markers of apoptosis and meiotic segregation in ejaculated sperm of chromosomal translocation carrier patients. Hum Reprod, 21, 685-693, 2006.
  8. Cauffman G, Liebaers I, Van Steirteghem A, Van de Velde H. POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells, 24, 2685-2691, 2006.
  9. De Sutter P, Bontinck J, Schutysers V, Van der Elst J, Gerris J, Dhont M. First-trimester bleeding and pregnancy outcome in singletons after assisted reproduction. Hum Reprod, 21, 1907-11, 2006
  10. De Sutter P, Delbaere I, Gerris J, Verstraelen H, Goetgeluk S, Van der Elst J, Temmerman M, Dhont M. Birthweight of singletons after assisted reproduction is higher after single- than after double-embryo transfer. Hum Reprod, 21, 2633-7, 2006
  11. Donoso P, Devroey P. PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol, Nov 2, 2006.
  12. Donoso P, Platteau P, Papanikolaou EG, Staessen C, Van Steirteghem A, Devroey P. Does PGD for aneuploidy screening change the selection of embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men? Hum Reprod, 21, 2390-2395, 2006.
  13. ESHRE Task Force on Ethics and Law; Pennings G, de Wert G, Shenfield F, Cohen J, Devroey P, Tarlatzis B. ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod, 21, 3050-3053, 2006.
  14. Everaert K, De Croo I, Kerckhaert W, Dekuyper P, Dhont M, Van der Elst J, De Sutter P, Comhaire F, Mahmoud A, Lumen N. Long term effects of micro-surgical testicular sperm extraction on androgen status in patients with non obstructive azoospermia.
    BMC Urol,  20, 6:9, 2006
  15. Fatemi HM, Kolibianakis EM, Camus M, Tournaye H, Donoso P, Papanikolaou E, Devroey P. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod, 21, 2628-32, 2006.
  16. Fatemi HM, Camus M, Kolibianakis EM, Tournaye H, Papanikolaou EG, Donoso P, Devroey P. The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. Fertil Steril, Nov 28, 2006.
  17. Geens M, De Block G, Goossens E, Frederickx V, Van Steirteghem A, Tournaye H. Spermatogonial survival after grafting human testicular tissue to immunodeficient mice. Hum Reprod, 21, 390-396, 2006.
  18. Goossens E, Frederickx V, De Block G, Van Steirteghem A, Tournaye H. Evaluation of in vivo conception after testicular stem cell transplantation in a mouse model shows altered post-implantation development. Hum Reprod, 21, 2057-2060, 2006.
  19. Goossens E, Frederickx V, De Block G, Van Steirteghem A, Tournaye H. Blastocyst development after assisted reproduction using spermatozoa obtained after testicular stem cell transplantation in mice. Hum Reprod, 21, 1759-64, 2006.
  20. Goossens E, Tournaye H. Testicular stem cells. Semin Reprod Med, 24, 370-378, 2006.
  21. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update, 12, 159-68, 2006.
  22. Griesinger G, Diedrich K, Devroey P; Kolibianakis E. Reply: Agonist trigger in the context of OHSS prevention: primum non nocere. Hum Reprod Update, 12, 328-329, 2006.
  23. Heindryckx B, Van der Elst J, Dhont M. Culture medium preferences of pre-implantation cloned mouse embryos. Methods Mol Biol, 348:59-78, 2006.
  24. Kastrop P, Van der Elst J. Richtlijn 2004/23/EG: consequenties van Europese wetgeving. Tijdschrift voor Fertiliteitsonderzoek, juni 2006
  25. Kolibianakis E, Devroey P, Van Steirteghem A. Ovulation induction and assisted reproduction. In book Endocrinology, fifth edition, LJ. DeGroot, JL. Jameson (eds), Saunders Elsevier, chapter 158, vol 3, 2983-2992, 2006.
  26. Kolibianakis E, Papanikolaou E, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod, 21, 352-357, 2006.
  27. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem A, Devroey P. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists. Hum Reprod, 21, 1012-1017, 2006.
  28. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update, 12, 3-12, 2006.
  29. Kolibianakis EM, Collins J, Tarlatzis BC, Devroey P, Diedrich K, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update, 12, 651-71, 2006.
  30. Kosmas IP, Tatsioni A, Fatemi HM, Kolibianakis EM, Tournaye H, Devroey P. Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. Fertil Steril, Dec 13, 2006.
  31. Le Caignec C; Spits C, Sermon K, De Rycke M, Thienpont B, Debrock S, Staessen C, Moreau Y, Fryns JP, Van Steirteghem A, Liebaers I, Vermeesch JR. Single-cell chromosomal imbalances detection by array CGH. Nucleic Acids Res, 34, e68, 2006.
  32. Liu J, Schoonjans L, Tielens S, Speleman F, Cornelissen M, De Sutter P, Dhont M, Van der Elst J.  Culturing in vitro produced blastocysts in sequential media promotes ES cell derivation. Mol Reprod Dev, 73, 1017-21, 2006.
  33. Mateizel I, De Temmerman N, Ullmann U, Cauffman G, Sermon K, Van de Velde H, De Rycke M, Degreef E, Devroey P, Liebaers I, Van Steirteghem A. Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod, 21, 503-511, 2006.
  34. Mertes H, Pennings G, Van Steirteghem A. An ethical analysis of alternative methods to obtain pluripotent stem cells without destroying embryos. Hum Reprod, 21, 2749-2755, 2006.
  35. Michiels A, Van Assche E, Liebaers I, Van Steirteghem A, Staessen C. The analysis of one or two blastomeres for PGD using fluorescence in-situ hybridization. Hum Reprod, 21, 2396-2402, 2006.
  36. Ogur G, Van Assche E, Vegetti W, Verheyen G, Tournaye H, Bonduelle M, Van Steirteghem A, Liebaers I. Chromosomal segregation in spermatozoa of 14 Robertsonian translocation carriers. Mol Hum Reprod, 12, 209-215, 2006.
  37. Papanikolaou E, Camus M, Fatemi H, Tournaye H, Verheyen G, Van Steirteghem A, Devroey P. Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. Reprod Biomed Online, 1, 60-5, 2006.
  38. Papanikolaou E, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med, 354, 1139-46, 2006.
  39. Papanikolaou E, Pozzobon C, Kolibianakis E, Camus M, Tournaye H, Fatemi H, Van Steirteghem A, Devroey P. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril, 85, 112-120, 2006.
  40. Pennings G, Devroey P. Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers. Reprod Biomed Online, 13(1), 8-10, 2006.
  41. Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P. Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening? Reprod Biomed Online, 12, 334-9, 2006.
  42. Platteau P, Andersen AN, Balen A, Devroey P, Sorensen P, Helmgaard L, Arce JC; Menopur Ovulation Induction (MOI) Study Group. Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. Hum Reprod, 21, 1798-804, 2006.
  43. Poppe K, Glinoer D, Tournaye H, Maniewski U, Haentjens P, Velkeniers B. Is systematic screening for thyroid disorders indicated in subfertile men? Eur J Endocrinol, Mar; 154(3):363-6, 2006.
  44. Poppe K, Glinoer D, Tournaye H, Devroey P, Schiettecatte J, Haentjens P, Velkeniers B. Thyroid autoimmunity and female infertility. Verh K. Acad. Geneesk. Belg. Vol. 68 (5-6), 357-377, 2006.
  45. Smitz J, Picton HM, Platteau P, Rutherford A, Cortvrindt R, Clyde J, Nogueira D, Devroey P, Lyby K, Grondahl C. Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. Fertil Steril, Dec 29, 2006.
  46. Smitz J, Andersen AN, Devroey P, Arce JC. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum Reprod, Nov 16, 2006.
  47. Soleimani R, De Vos W, Van Oostveldt P, Lierman S, Van den Broecke R, De Sutter P, Dhont M, Van der Elst J. Two novel techniques to detect follicles in human ovarian cortical tissue. Hum Reprod, 21, 1720-4, 2006.
  48. Spits C, De Rycke M, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K. Preimplantation genetic diagnosis for Marfan syndrome. Fertil Steril, 86, 310-20, 2006.
  49. Spits C, Le Caignec C, De Rycke M, Van Haute L, Van Steirteghem A, Liebaers I, Sermon K. Optimization and evaluation of single-cell whole-genome multiple displacement amplification. Hum Mutat, 27, 496-503, 2006.
  50. Stouffs K, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. Alterations of the USP26 gene in Caucasian men. Int J Androl, 29, 614-7, 2006.
  51. Stouffs K, Willems A, Lissens W, Tournaye H, Van Steirteghem A, Liebaers I. The role of the testis-specific gene hTAF7L in the aetiology of male infertility. Mol Hum Reprod, 12, 263-267, 2006.
  52. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update, 12(4), 333-40, 2006. in: Hum Reprod Update. 2006 Nov-Dec;12(6):797. Rombauts, L [added], 2006
  53. Tavaniotou A, Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online, 13(3), 326-30, 2006
  54. Tielens S, Verhasselt B, Liu J, Dhont M, Van Der Elst J, Cornelissen M. Generation of embryonic stem cell lines from mouse blastocysts developed in vivo and in vitro: relation to Oct-4 expression. Reproduction, 132, 59-66, 2006
  55. Tournaye H. Evidence-based management of male subfertility. Curr Opin Obstet Gynecol, Jun; 18(3):253-9, 2006.
  56. Tournaye H. Spijt na vasectomie: wat nu? Agenda Andrologie.
  57. Tournaye H. Het chirurgisch verkrijgen van epidimaire en testiculaire zaadcellen. TFO, 20, 1B, 12-15, 2006
  58. Tournaye H. Male contributions to the biology of conception and fertilization. In: "Andrology for the Clinician" by Wolf-Bernhard Schill (Editor), Frank H. Comhaire (Editor), Timothy B. Hargreave (Editor). Springer Verlag, 2006.
  59. Tournaye H and Goossens E. Adult stem cell population in the testis. In; "Stem cells in Human Reproduction, Basic Science and Therapeutic Potential" by Simon C and Pellicer A (Editors), Informa, London, pp 77-90, 2006.
  60. Tournaye H. Intracytoplasmatische sperma injectie met chirurgisch verkregen zaad. Welke techniek moet men toepassen en welk resultaat kan men verwachten?, Agenda Andrologie.
  61. Tournaye H. Evidence-based behandelen van mannelijke subfertiliteit, Agenda Andrologie
    Van de Velde H, De Rycke M, Liebaers I. HLA-typering en pre-implantatie genetische diagnose. TFO, 20, 3B, 65-71, 2006.
  62. Van de Velde H, De Rycke M and Liebaers I. HLA typing and preimplantation genetic diagnosis. Revue de la Société de Médicine de la reproduction. 8, 273-280, 2006.
  63. Van der Elst J. Kinderen zonder zwangerschap. De toekomstvoorspeller. Tijdschrift Universiteit Gent, januari 2006
  64. Van der Elst J. Kinderen zonder zwangerschap. De toekomstvoorspeller. Tijdschrift Universiteit Gent, januari 2006.
  65. Van der Elst J. Vrouwen moeten bewust keuzes maken. Artsenkrant, p14, 12 mei 2006
  66. Van Landuyt L, Verheyen G, Tournaye H, Camus M, Devroey P, Van Steirteghem A. New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate. Reprod Biomed Online, 13, 765-71, 2006.
  67. Van Steirteghem A, Van der Elst J. "We willen koppels, hetero of homo, een gezond en gelukkig kind geven", AKADEMOS, infomagazine van de VUB, 9, p4-5, april 2006.
  68. Verheyen G. Cryopreservatie van testiculaire zaadcellen. TFO, 20, 2, 26-32, 2006
  69. Vernaeve V, Verheyen G, Goossens A, Van Steirteghem A, Devroey P, Tournaye H. How successful is repeat testicular sperm extraction in patients with azoospermia? Hum Reprod, 21, 1551-1554, 2006.
  70. Verpoest W, Tournaye H. ICSI: hype or hazard. A review. Human Fertility Jun 4; 9(2): 81-92, 2006.
  71. Verpoest WM, Kolibianakis E, Papanikolaou E, Smitz J, Van Steirteghem A, Devroey P. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online, 13, 166-72, 2006.
Top